Search Results - "B.S."
Suggested Topics within your search.
Suggested Topics within your search.
- COVID-19 6
- COVID-19 (Disease) 6
- Clinical Trials as Topic 6
- Clinical trials 6
- Coronavirus infections 6
- SARS-CoV-2 6
- administration & dosage 6
- drug therapy 6
- Antiviral agents 4
- Chemotherapy 4
- Coronavirus Infections 4
- Pneumonia, Viral 4
- Research 4
- Therapeutic use 4
- immunology 4
- Antibodies, Monoclonal 2
- Antibodies, Neutralizing 2
- Antibodies, Viral 2
- Antibody-drug conjugates 2
- Antigens, CD 2
- Antigens, Neoplasm 2
- Antineoplastic Agents 2
- Antineoplastic agents 2
- Antiviral Agents 2
- B-Lymphocytes 2
- COVID-19 Vaccines 2
- Cancer 2
- Combined Modality Therapy 2
- Communicable Diseases, Emerging 2
- Development 2
-
1
Interferon-α2b as a therapy for COVID-19
Published 2020Table of Contents: “…Contents: Molecular basis of IFN-α2b use and past indications -- Best use of IFN-α2b as therapy -- Mode of administration -- IFN-α2b use in combination therapy -- Next steps in the study.…”
Get full text
Series
Electronic Audio -
2
Interferon-α2b as a therapy for COVID-19
Published 2020Table of Contents: “…Contents: Molecular basis of IFN-α2b use and past indications -- Best use of IFN-α2b as therapy -- Mode of administration -- IFN-α2b use in combination therapy -- Next steps in the study.…”
Get full text
Series
Electronic Audio -
3
mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals
Published 2021Table of Contents: “…Contents: Monitoring the levels of immune cells, e.g. memory B cells, rather than levels of antibodies, as an indication of long term immune protection -- The efficacy of vaccines in previously infected vs previously uninfected individuals -- The efficacy of a single vs double dose -- The potential value of administrating a "booster" that is different from the previous administered vaccine in an individual, AKA "mixing-and-matching".…”
Get full text
Series
Electronic Audio -
4
mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals
Published 2021Table of Contents: “…Contents: Monitoring the levels of immune cells, e.g. memory B cells, rather than levels of antibodies, as an indication of long term immune protection -- The efficacy of vaccines in previously infected vs previously uninfected individuals -- The efficacy of a single vs double dose -- The potential value of administrating a "booster" that is different from the previous administered vaccine in an individual, AKA "mixing-and-matching".…”
Get full text
Series
Electronic Audio -
5
The development of therapeutic antibodies against oncogenic antigens
Published 2020Table of Contents: “…Contents: The development of naked and drug-conjugated antibodies against endoglin and CD75b -- The results of recent clinical trials with both therapeutic antibodies -- Advantages and challenges in the development of naked and drug-conjugated antibodies.…”
Get full text
Series
Electronic Audio -
6
The development of therapeutic antibodies against oncogenic antigens
Published 2020Table of Contents: “…Contents: The development of naked and drug-conjugated antibodies against endoglin and CD75b -- The results of recent clinical trials with both therapeutic antibodies -- Advantages and challenges in the development of naked and drug-conjugated antibodies.…”
Get full text
Series
Electronic Audio -
7
-
8
-
9
